VLA — Valneva SE Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Valneva SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-64.4	-73.4	-143	-101	-12.2
Depreciation
Non-Cash Items	117	102	-126	28.3	-61.4
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	75.8	34.5	5.86	-147	-13.1
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	138	76.9	-242	-203	-67.2
Capital Expenditures	-19.5	-93.2	-29.3	-14.3	-16.4
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.131	0.055	0.268	-6.27	93.4
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-19.3	-93.1	-29.1	-20.6	76.9
Financing Cash Flow Items	-4.71	-8.42	-9.21	-12.6	-20
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	21.7	155	215	63.1	30.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	140	142	-57.2	-160	42.2